ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 22

Bone Regulatory Cytokine Production By B Cells in Rheumatoid Arthritis Is Dependent on NF-κb Activation and Autophagy Pathways

Jason Glanzman1, Nida Meednu1, Victor Wang1, Wen Sun2, Lianping Xing3 and Jennifer H. Anolik1, 1Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Nanjing Medical University, Nanjing, China, 3Pathology & Lab Medicine, University of Rochester Medical Center, Rochester, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: B cells, cytokines and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Session Title: B Cell Biology and Targets in Autoimmune Disease Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease that often leads to joint damage, a process mediated by an imbalance between bone resorption and bone formation. B cells play a role in bone homeostasis in RA, and evidence suggests that B cells can affect function of both osteoblasts (OB) and osteoclasts (OC). In mouse models of RA, B cells were enriched in the subchondral bone marrow (BM) and synovium, and were adjacent to the bone surface. These B cells produce the inflammatory cytokines TNFα and CCL3, which drive dysregulation of bone homeostasis via their OB inhibitory and OC stimulatory effects. In vitro, synergistic production of these cytokines results from co-activation of the B cell receptor (BCR) and toll-like receptor 9 (TLR9). Therefore, we investigated the mechanisms underlying synergistic TNFα/CCL3 production by B cells in response to BCR and TLR9 co-activation.

Methods: Isolated B cells from peripheral blood of healthy controls (HC) were stimulated with 10 µg/mL anti-Ig (A+M+G) and CpG2006 for 4 hours, and production of TNFα and CCL3 was assessed by ELISA and qPCR. Multiple specific inhibitors were used to test the involvement of BCR, TLR9, and NF-κB signaling, as well as autophagy. Data is presented as mean±SEM. Statistical significance was determined by student’s t-test.

Results: Stimulation of B cells with α-Igs and CpG2006 induced significant production of TNFα and CCL3 compared to unstimulated B cells at mRNA and protein levels. Furthermore, cytokine production was significantly higher than levels from α-Igs or CpG2006 stimulations alone, suggesting a synergistic effect (CpG+α-Igs vs. CpG vs. α-Igs (ng/mL): TNFα: 2.71±0.42 vs. 0.33±0.04 (P<0.0001) vs. 0.70±0.23 (P=0.0008), CCL3: 3.69±1.00 vs. 0.77±0.29 (P=0.0031) vs. 0.64±0.18 (P=0.0037)). This synergistic production was dependent on TLR9 and BCR signaling, as blocking B cells with hydroxychloroquine (TLR inhibitor) or PP2 (Src kinase inhibitor) reduced cytokine production to non-synergistic levels. Additionally, blocking BCR internalization with MDC also reduced TNFα and CCL3 production. To investigate signaling downstream of BCR/TLR9 synergy, we tested inhibitors against classical NF-κB (TPCA-1), non-classical NF-κB (NIK inhibitor) and AP-1. We found that BCR/TLR9 synergy was classical NF-κB dependent (CpG+α-Igs vs. CpG+α-Igs+TPCA-1 (ng/mL): TNFα: 2.5±0.44 vs. 0.33±0.14 (P=0.009), CCL3: 1.9±0.3 vs. 0.83±0.08 (P=0.027)). Finally, we inhibited autophagy using class III PI3K inhibitor 3-methyladenine which reduced TNFα and CCL3 production to non-synergistic levels, suggesting that BCR/TLR9 synergy depends on autophagy (CpG+α-Igs vs. CpG+α-Igs+3-MA (ng/mL): TNFα: 1.5±0.25 vs. 0.4±0.04 (P=0.0058), CCL3: 4.1±1.15 vs. 0.82±0.35 (P=0.033)). Investigation of the specific autophagy pathway involved is currently underway.

Conclusion: Dual activation of B cells through the BCR and TLR9 synergistically enhanced TNFα and CCL3 production in a classical NF-κB, and autophagy-dependent manner. These results characterize key mechanistic events in the synergistic production of bone regulatory cytokines by B cells, a process that contributes to the dysregulation of bone homeostasis in RA.


Disclosure: J. Glanzman, None; N. Meednu, None; V. Wang, None; W. Sun, None; L. Xing, None; J. H. Anolik, None.

To cite this abstract in AMA style:

Glanzman J, Meednu N, Wang V, Sun W, Xing L, Anolik JH. Bone Regulatory Cytokine Production By B Cells in Rheumatoid Arthritis Is Dependent on NF-κb Activation and Autophagy Pathways [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/bone-regulatory-cytokine-production-by-b-cells-in-rheumatoid-arthritis-is-dependent-on-nf-%ce%bab-activation-and-autophagy-pathways/. Accessed January 27, 2023.
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/bone-regulatory-cytokine-production-by-b-cells-in-rheumatoid-arthritis-is-dependent-on-nf-%ce%bab-activation-and-autophagy-pathways/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences